Palabras clave
COVID-19
Taquicardia sinusal
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar la literatura buscando comprender mejor la presencia de arritmias cardíacas en el Síndrome Post-Covid. Revisión bibliográfica: La prevalencia de cambios electrocardiográficos en pacientes con Covid Longa ha sido alta. La alteración más frecuentemente encontrada fue la taquicardia sinusal, que parece ser causada por dos síndromes con mecanismos similares, que son el Síndrome de Taquicardia Ortostática Postural y el Síndrome de Taquicardia Sinusal Inapropiada. La fisiopatología parece ser el daño causado al Sistema Nervioso Autonómico, a través de una activación autoinmune que se produce tras la infección viral. Además, se encontraron otros eventos arrítmicos en estos pacientes, como el desarrollo de arritmias auriculares y ventriculares asociadas a miocarditis viral. Consideraciones finales: A pesar de la alta prevalencia y carga sobre la población afectada, falta evidencia científica que busque comprender los mecanismos arritmogénicos provocados por el SARS-CoV-2. Además, es de suma importancia establecer protocolos que permitan un cribado óptimo de estos pacientes lo antes possible.
Referencias
ABBOUD H, et al. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg, 2020; 140: 49-53.
ALI M, et al. Inappropriate sinus tachycardia: a review. Rev Cardiovasc Med, 2021; 22(4):1331-1339.
ARANYÓ J, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep, 2022; 12(1): 298.
BEGIENEMAN MP, et al. Ventricular myocarditis coincides with atrial myocarditis in patients. Cardiovasc Pathol, 2016; 25(2): 141-8.
BLAGOVA O, et al. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol, 2021; 51(4): 893-902.
DAVIS HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 2021; 38: 101019.
EVANS RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med, 2021; 9(11): 1275-1287.
GAWAŁKO M, et al. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc, 2020; 30: 100631.
GOLDBERGER J, et al. Autonomic Nervous System Dysfunction: JACC Focus Seminar. J Am Coll Cardiol, 2019; 73(10): 1189-1206.
HOFFMANN M, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 2020; 181(2): 271-280.
HONARDOOST M, et al. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Cerebrovasc Dis, 2021; 50(2): 132-140.
HUANG C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021; 397(10270): 220-232.
INGUL CB, et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J Am Heart Assoc, 2022; 11(3): e023473.
JOHANSSON M, et al. COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience. JACC Case Rep, 2021; 3(4): 573-580.
KITSOU V, et al. Intermittent left bundle branch block with septal flash and postural orthostatic tachycardia syndrome in a young woman with long COVID-19. BMJ Case Rep, 2022; 15(6): e249608.
LIU T, et al. Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clin Infect Dis, 2022; 74(11): 1953-1965.
MITRANI RD, et al. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm, 2020; 17(11): 1984-1990.
MOHAMMAD M, et al. Cardiac arrhythmias associated with COVID-19 infection: state of the art review. Expert Rev Cardiovasc Ther, 2021; 19(10): 881-889.
NASCIMENTO JHP, et al. COVID-19 and Myocardial Injury in a Brazilian ICU: High Incidence and Higher Risk of In-Hospital Mortality. Arq Bras Cardiol, 2021; 116(2): 275-282.
National Institute for Health and Care Excellence, 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. Disponível em: https://www.nice.org.uk/guidance/ng188. Acessado em: 18 de Agosto de 2022
PERETTO G, et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J Am Coll Cardiol, 2020; 75(9): 1046-1057.
POLLACK A, et al. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol, 2015; 12(11): 670-80.
PUNTMANN VO, et al. Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, 2020; 5(11): 1265-1273.
RAMAN B, et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J, 2022; 43(11): 1157-1172.
REYNBAKH O, et al. Arrhythmia patterns during and after hospitalization for COVID-19 infection detected via patch-based mobile cardiac telemetry. Am Heart J Plus, 2022; 13: 100084.
STÅHLBERG M, et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am J Med, 2021; 134(12): 1451-1456.
SIRIPANTHONG B, et al. The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury. JACC Basic Transl Sci, 2022; 7(3): 294-308.
SUTHANAR N, et al. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep, 2017; 14(4): 235-250.
SWAI J, et al. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovasc Disord, 2019; 19(1): 320.
VERNINO S, STILES LE. Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding. Auton Neurosci, 2018; 215: 78-82.
WORLD HEALTH ORGANIZATION (WHO).WHO COVID-19 Dashboard. 2022. World Health Organization, Geneve. Disponível em: https://covid19.who.int/. Acessado em: 16 de Agosto de 2020.
YU CM, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J, 2006; 82(964): 140-4.
ZYLLA MM, et al. Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19. J Clin Med, 2021; 10(1): 133.